Sustainability Remains Top-of-Mind for Pharmaceutical Industry

May 5, 2022

Only a few short years ago, pharmaceutical manufacturers viewed supplier sustainability initiatives as a nice-to-have, but not a deciding factor in their decision to do business together. That shifted in 2020 with companies focusing on how they could impact the United Nations’ Sustainability Development Goals (SDGs), as well as building plans to execute and measure their efforts.

What began as internal initiatives quickly turned to a focus on how vendor and supplier sustainability initiatives impact a company’s sustainability goals. Pharmaceutical companies soon required vendors like Peli BioThermal to demonstrate that temperature-controlled packaging and modes of transportation minimize negative effects on the environment. Additionally, vendors were also asked to provide tools that help pharmaceutical manufacturers measure their actual environmental impact so they can monitor and demonstrate reductions in carbon footprint and waste.

Learn more about how biopharma industry leaders are increasing the pace to prioritize sustainability in business and operational strategies, or dig deeper into our environmental impact comparison of packaging methods in the cold chain industry.